ATTENTION: The software behind KU ScholarWorks is being upgraded to a new version. Starting July 15th, users will not be able to log in to the system, add items, nor make any changes until the new version is in place at the end of July. Searching for articles and opening files will continue to work while the system is being updated.
If you have any questions, please contact Marianne Reed at mreed@ku.edu .
Potency enhancement of the κ-opioid receptor antagonist probe ML140 through sulfonamide constraint utilizing a tetrahydroisoquinoline motif
dc.contributor.author | Frankowski, Kevin J. | |
dc.contributor.author | Slauson, Stephen R. | |
dc.contributor.author | Movell, Kimberly M. | |
dc.contributor.author | Phillips, Angela M. | |
dc.contributor.author | Streicher, John M. | |
dc.contributor.author | Zhou, Lei | |
dc.contributor.author | Whipple, David A. | |
dc.contributor.author | Schoenen, Frank J. | |
dc.contributor.author | Prisinzano, Thomas E. | |
dc.contributor.author | Bohn, Laura M. | |
dc.contributor.author | Aubé, Jeffrey | |
dc.date.accessioned | 2017-05-10T18:26:15Z | |
dc.date.available | 2017-05-10T18:26:15Z | |
dc.date.issued | 2015-07-15 | |
dc.identifier.citation | Frankowski, K. J., Slauson, S. R., Lovell, K. M., Phillips, A. M., Streicher, J. M., Zhou, L., … Aubé, J. (2015). Potency enhancement of the κ-opioid receptor antagonist probe ML140 through sulfonamide constraint utilizing a tetrahydroisoquinoline motif. Bioorganic & Medicinal Chemistry, 23(14), 3948–3956. http://doi.org/10.1016/j.bmc.2014.12.033 | en_US |
dc.identifier.uri | http://hdl.handle.net/1808/24079 | |
dc.description.abstract | Optimization of the sulfonamide-based kappa opioid receptor (KOR) antagonist probe molecule ML140 through constraint of the sulfonamide nitrogen within a tetrahydroisoquinoline moiety afforded a marked increase in potency. This strategy, when combined with additional structure-activity relationship exploration, has led to a compound only six-fold less potent than norBNI, a widely utilized KOR antagonist tool compound, but significantly more synthetically accessible. The new optimized probe is suitably potent for use as an in vivo tool to investigate the therapeutic potential of KOR antagonists. | en_US |
dc.publisher | Elsevier | en_US |
dc.rights | This article is made available under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported (CC BY-NC-ND 3.0) License. | en_US |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/3.0/ | en_US |
dc.subject | Kappa Opioid Receptor | en_US |
dc.subject | Antagonist | en_US |
dc.subject | Molecular constraint | en_US |
dc.subject | Potency enhancement | en_US |
dc.subject | Tetrahydroisoquinoline | en_US |
dc.title | Potency enhancement of the κ-opioid receptor antagonist probe ML140 through sulfonamide constraint utilizing a tetrahydroisoquinoline motif | en_US |
dc.type | Article | en_US |
kusw.kuauthor | Frankowski, Kevin J. | |
kusw.kuauthor | Slauson, Stephen R. | |
kusw.kuauthor | Whipple, David A. | |
kusw.kuauthor | Schoenen, Frank J. | |
kusw.kuauthor | Prisinzano, Thomas E. | |
kusw.kuauthor | Aubé, Jeffrey | |
kusw.kudepartment | Specialized Chemistry Center | en_US |
dc.identifier.doi | 10.1016/j.bmc.2014.12.033 | en_US |
dc.identifier.orcid | https://orcid.org/0000-0003-1049-5767 https://orcid.org/0000-0002-2811-2894 | |
kusw.oaversion | Scholarly/refereed, author accepted manuscript | en_US |
kusw.oapolicy | This item meets KU Open Access policy criteria. | en_US |
dc.identifier.pmid | PMC4468036 | en_US |
dc.rights.accessrights | openAccess |